In this program, the decision is not whether a technology should be funded in general, but whether it is justified to try here and now for this person. That is a fundamentally different ethical architecture from the HTA institutional frameworks we have. …
The two sides of decision-making - compassion and calculation in funding outcomes
February 22, 2026 Latest NewsBioPharmaComment
Latest Video
Georgia Forrest
New Stories
-
Scientists identify highly specific targets that could transform multiple myeloma treatment
March 15, 2026 - - Australian Biotech -
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News -
The leadership challenge behind Australia’s medicine access gap
March 13, 2026 - - Latest News -
Australia’s top community pharmacists honoured at national awards
March 13, 2026 - - Latest News -
Australia has spent four decades having the wrong conversation about medicines access
March 13, 2026 - - Latest News -
‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event
March 13, 2026 - - Latest News